|
|
|
|
|
|
|
Shared Set
|
|
|
|
|
|
|
MP:0002675 |
asthenozoospermia |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
2.65E-02 |
3 |
11 |
Shared |
Eno4, Gapdhs, Pgk2
|
MP:0009835 |
absent sperm annulus |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
3.47E-02 |
1 |
11 |
Shared |
Eno4
|
MP:0005642 |
decreased mean corpuscular hemoglobin concentration |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
3.66E-02 |
2 |
11 |
Shared |
Gpi1, Tpi1
|
MP:0011609 |
decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
2.65E-02 |
1 |
11 |
Shared |
Gapdh
|
MP:0006205 |
embryonic lethality between implantation and somite formation |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
2.65E-02 |
3 |
11 |
Shared |
Eno1, Gapdh, Tpi1
|
|
|
|
|
|
|
|
Glycolysis
|
|
|
|
|
|
|
MP:0008859 |
abnormal hair cycle catagen phase |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.93E-02 |
1 |
9 |
Glycolysisis-Specific |
Pfkl
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0003731 |
abnormal retina outer nuclear layer morphology |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.93E-02 |
2 |
9 |
Glycolysisis-Specific |
Hkdc1, Pkm
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0004952 |
increased spleen weight |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.82E-02 |
2 |
9 |
Glycolysisis-Specific |
Hk1, Pfkm
|
8.36E-02 |
2 |
11 |
Shared |
Gpi1, Tpi1
|
MP:0013404 |
decreased circulating lactate level |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.65E-02 |
1 |
9 |
Glycolysisis-Specific |
Pfkm
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0010035 |
increased erythrocyte clearance |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.65E-02 |
1 |
9 |
Glycolysisis-Specific |
Pklr
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0001585 |
hemolytic anemia |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
6.18E-03 |
2 |
9 |
Glycolysisis-Specific |
Hk1, Pklr
|
1.12E-01 |
1 |
11 |
Shared |
Tpi1
|
MP:0003059 |
decreased insulin secretion |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
3.76E-02 |
2 |
9 |
Glycolysisis-Specific |
Gck, Pfkm
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0031085 |
increased erythrocyte osmotic fragility |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
3.08E-03 |
2 |
9 |
Glycolysisis-Specific |
Pfkm, Pklr
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0011606 |
decreased glucokinase activity |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
1.84E-02 |
1 |
9 |
Glycolysisis-Specific |
Gck
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0005293 |
impaired glucose tolerance |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
2.78E-02 |
3 |
9 |
Glycolysisis-Specific |
Gck, Hkdc1, Pfkm
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0005639 |
hemosiderosis |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.82E-02 |
1 |
9 |
Glycolysisis-Specific |
Pklr
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0010375 |
increased kidney iron level |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.93E-02 |
1 |
9 |
Glycolysisis-Specific |
Hk1
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0000245 |
abnormal erythropoiesis |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
3.77E-02 |
2 |
9 |
Glycolysisis-Specific |
Hk1, Pklr
|
2.28E-01 |
1 |
11 |
Shared |
Tpi1
|
MP:0002814 |
hyperchromasia |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.36E-02 |
1 |
9 |
Glycolysisis-Specific |
Hk1
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0002590 |
increased mean corpuscular volume |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.65E-02 |
2 |
9 |
Glycolysisis-Specific |
Hk1, Pklr
|
8.02E-02 |
2 |
11 |
Shared |
Gpi1, Tpi1
|
MP:0031318 |
enhanced skeletal muscle regeneration |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.65E-02 |
1 |
9 |
Glycolysisis-Specific |
Pfkm
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0000208 |
decreased hematocrit |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
1.11E-02 |
3 |
9 |
Glycolysisis-Specific |
Hk1, Pfkm, Pklr
|
9.30E-02 |
2 |
11 |
Shared |
Gpi1, Tpi1
|
MP:0002640 |
reticulocytosis |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
1.94E-03 |
3 |
9 |
Glycolysisis-Specific |
Hk1, Pfkm, Pklr
|
3.47E-02 |
2 |
11 |
Shared |
Gpi1, Tpi1
|
MP:0005344 |
increased circulating bilirubin level |
3.16E-01 |
1 |
19 |
Gluconeogenesis-Specific |
Slc37a1
|
4.60E-03 |
3 |
9 |
Glycolysisis-Specific |
Hk1, Pfkm, Pklr
|
5.87E-02 |
2 |
11 |
Shared |
Gpi1, Tpi1
|
MP:0000874 |
irregular external granule cell layer thickness |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
1.34E-02 |
1 |
9 |
Glycolysisis-Specific |
Hk2
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0006353 |
increased glycosylated hemoglobin level |
1.00E+00 |
0 |
19 |
Gluconeogenesis-Specific |
|
4.52E-02 |
1 |
9 |
Glycolysisis-Specific |
Gck
|
1.00E+00 |
0 |
11 |
Shared |
|
|
|
|
|
|
|
|
Gluconeogenesis
|
|
|
|
|
|
MP:0000334 |
decreased granulocyte number |
3.08E-02 |
3 |
19 |
Gluconeogenesis-Specific |
G6pc3, Got1, Slc37a4
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0003864 |
abnormal midbrain development |
2.44E-02 |
2 |
19 |
Gluconeogenesis-Specific |
Got2, Mdh2
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0001731 |
abnormal postnatal growth |
4.63E-02 |
5 |
19 |
Gluconeogenesis-Specific |
G6pc, G6pc3, Pck1, Slc25a12, Slc37a4
|
4.40E-01 |
1 |
9 |
Glycolysisis-Specific |
Gck
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0003383 |
abnormal gluconeogenesis |
3.08E-02 |
2 |
19 |
Gluconeogenesis-Specific |
Pcx, Slc25a13
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0013405 |
increased circulating lactate level |
7.85E-03 |
2 |
19 |
Gluconeogenesis-Specific |
Pck1, Pcx
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0002575 |
increased circulating ketone body level |
1.62E-02 |
2 |
19 |
Gluconeogenesis-Specific |
Pck1, Pcx
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0000189 |
hypoglycemia |
9.96E-07 |
6 |
19 |
Gluconeogenesis-Specific |
Fbp1, G6pc, Pck1, Pcx, Slc25a13, Slc37a4
|
1.27E-01 |
1 |
9 |
Glycolysisis-Specific |
Gck
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0002628 |
hepatic steatosis |
5.28E-03 |
4 |
19 |
Gluconeogenesis-Specific |
G6pc, Pck1, Pcx, Slc25a13
|
1.97E-01 |
1 |
9 |
Glycolysisis-Specific |
Gck
|
3.26E-01 |
1 |
11 |
Shared |
Aldob
|
MP:0009355 |
increased liver triglyceride level |
6.31E-04 |
4 |
19 |
Gluconeogenesis-Specific |
G6pc, Pck1, Pcx, Slc25a13
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0010400 |
increased liver glycogen level |
1.61E-02 |
2 |
19 |
Gluconeogenesis-Specific |
G6pc, Slc37a4
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0002644 |
decreased circulating triglyceride level |
3.58E-02 |
3 |
19 |
Gluconeogenesis-Specific |
G6pc2, Pck1, Pck2
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
1.00E+00 |
0 |
11 |
|
|
MP:0001552 |
increased circulating triglyceride level |
7.05E-03 |
4 |
19 |
|
G6pc, Pck1, Pcx, Slc37a4
|
2.09E-01 |
1 |
9 |
Glycolysisis-Specific |
Gck
|
1.00E+00 |
0 |
11 |
Shared |
|
MP:0031003 |
increased kidney glycogen level |
5.28E-04 |
2 |
19 |
Gluconeogenesis-Specific |
G6pc, Slc37a4
|
1.00E+00 |
0 |
9 |
Glycolysisis-Specific |
|
1.00E+00 |
0 |
11 |
Shared |
|